In this Issue:
Efficacy and safety of baricitinib in RA
Cost-effectiveness of etanercept vs DMARD triple therapy
Mavrilimumab for rheumatoid arthritis
Urate deposition in asymptomatic hyperuricemia vs symptomatic gout
Osteoporosis in men
Osteoporosis in young women
Anti-TNF-treated RA patients undergoing arthroplasty: infection risk
Etanercept biosimilar HD203 vs Enbrel® in RA
Zoster vaccination in biologic-treated patients
RCT of secukinumab in active ankylosing spondylitis
Please login below to download this issue (PDF)